159 related articles for article (PubMed ID: 35236377)
1. The comparative anti-cancer effects of krill oil and oxaliplatin in an orthotopic mouse model of colorectal cancer.
Jayathilake AG; Hassanzadeganroudsari M; Jovanovska V; Luwor RB; Nurgali K; Su XQ
Nutr Metab (Lond); 2022 Mar; 19(1):12. PubMed ID: 35236377
[TBL] [Abstract][Full Text] [Related]
2. Krill oil supplementation reduces the growth of CT-26 orthotopic tumours in Balb/c mice.
Jayathilake AG; Kadife E; Kuol N; Luwor RB; Nurgali K; Su XQ
BMC Complement Med Ther; 2022 Feb; 22(1):34. PubMed ID: 35120511
[TBL] [Abstract][Full Text] [Related]
3. Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9.
Jayathilake AG; Kadife E; Luwor RB; Nurgali K; Su XQ
Nutr Metab (Lond); 2019; 16():53. PubMed ID: 31428181
[TBL] [Abstract][Full Text] [Related]
4. Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression.
Jayathilake AG; Veale MF; Luwor RB; Nurgali K; Su XQ
BMC Complement Med Ther; 2020 Dec; 20(1):372. PubMed ID: 33287803
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
6. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
9. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2012 Mar; (571):1-186. PubMed ID: 22441424
[TBL] [Abstract][Full Text] [Related]
10. Effects of Antarctic krill oil on lipid and glucose metabolism in C57BL/6J mice fed with high fat diet.
Sun D; Zhang L; Chen H; Feng R; Cao P; Liu Y
Lipids Health Dis; 2017 Nov; 16(1):218. PubMed ID: 29157255
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the Gut Microbiota by Krill Oil in Mice Fed a High-Sugar High-Fat Diet.
Lu C; Sun T; Li Y; Zhang D; Zhou J; Su X
Front Microbiol; 2017; 8():905. PubMed ID: 28567037
[TBL] [Abstract][Full Text] [Related]
12. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
Lamoine S; Cumenal M; Barriere DA; Pereira V; Fereyrolles M; Prival L; Barbier J; Boudieu L; Brasset E; Bertin B; Renaud Y; Miot-Noirault E; Civiale MA; Balayssac D; Aissouni Y; Eschalier A; Busserolles J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008525
[TBL] [Abstract][Full Text] [Related]
13. Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice.
Skorve J; Hilvo M; Vihervaara T; Burri L; Bohov P; Tillander V; Bjørndal B; Suoniemi M; Laaksonen R; Ekroos K; Berge RK; Alexson SE
Lipids Health Dis; 2015 Aug; 14():88. PubMed ID: 26260413
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
17. Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice.
Tillander V; Bjørndal B; Burri L; Bohov P; Skorve J; Berge RK; Alexson SE
Nutr Metab (Lond); 2014; 11():20. PubMed ID: 24834104
[TBL] [Abstract][Full Text] [Related]
18. Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition.
Jang CH; Moon N; Lee J; Kwon MJ; Oh J; Kim JS
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453311
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA
PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114
[TBL] [Abstract][Full Text] [Related]
20. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
